Cases 1 - 10 of 237
Astellas Pharma, Inc. v. Aurobindo Pharma Ltd.
as 23-2089
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND et al v. CELGENE CORPORATION et al
as 2:2022cv06694
Plaintiff:
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND and JACKSONVILLE POLICE OFFICERS AND FIRE FIGHTERS HEALTH INSURANCE TRUST
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv05830
Defendant:
ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and others
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01291
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MYLAN INC. et al v. SOMAXON PHARMACEUTICALS, INC. et al
as 2:2022cv03944
Petitioner:
MYLAN INC. and MYLAN PHARMACEUTICALS INC.,
Plaintiff:
SOMAXON PHARMACEUTICALS, INC. and PROCOM ONE INC.
Respondent:
Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Interested Party:
PAR PHARMACEUTICAL INC, ACTAVIS ELIZABETH LLC, ACTAVIS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Somaxon Pharmaceuticals, Inc. et al v. ACTAVIS ELIZABETH et al
as 3:2022xc01290
Plaintiff:
Somaxon Pharmaceuticals Inc and Procom One Inc
Defendant:
Actavis Elizabeth LLC, Actavis Inc, Zydus Pharmaceuticals (USA), Inc. and others
Cause Of Action: 28 U.S.C. § 1330 Breach of Contract
Novartis Pharmaceuticals Corporation v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00440
Defendant:
Zydus Lifesciences Ltd., Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00439
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
